Hepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular Carcinoma
Clinical trial NCT05003700 · COMPLETED
Trial details
- NCT number
- NCT05003700
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-12
- Primary completion
- 2023-05-26
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.